WHAT REVIEWS REVEAL ABOUT OTC RELIEF
When consumers are sick, they want fast, reliable relief. This report explores how rising expectations are reshaping choice in the OTC cough, cold, and flu category—and where brands and private labels are gaining ground.
The OTC cough, cold, and flu category remains one of the most trusted segments in healthcare retail, with consumers consistently rating products highly during peak illness periods. At the same time, new competitive dynamics are emerging as private-label brands gain credibility and close the gap with established national brands.
In this report, Revuze analyzes more than 237,000 online reviews from major retailers, including Amazon, Walmart, CVS, and Target, to uncover how consumers evaluate relief products, which attributes matter most, and how the balance of power between national brands and control-label competitors is shifting.
To learn how we handle your information, please see our Privacy policy.
This site is protected by reCAPTCHA.
To learn how we handle your information, please see our Privacy policy.
This site is protected by reCAPTCHA.
To learn how we handle your information, please see our Privacy policy.
This site is protected by reCAPTCHA.